Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Johnson and Johnson
Harvard Business School
AstraZeneca
McKesson

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Litigation Details for Horizon Pharma AG v. Watson Laboratories, Inc. - Florida (S.D. Fla. 2013)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Horizon Pharma AG v. Watson Laboratories, Inc. - Florida (S.D. Fla. 2013)

Docket   Start Trial Date Filed 2013-08-28
Court District Court, S.D. Florida Date Terminated 2013-09-05
Cause 35:0271 Patent Infringement Assigned To Kevin Michael Moore
Jury Demand None Referred To Edwin G. Torres
Parties ACTAVIS PHARMA, INC.; ACTAVIS, INC.; ANDRX CORPORATION (A DELAWARE CORPORATION); HORIZON PHARMA AG; JAGOTEG AG; WATSON LABORATORIES, INC. - FLORIDA
Patents 6,488,960; 6,677,326; 8,168,218; 8,309,124; 8,394,407
Attorneys Eric David Isicoff; Susan Virginia Warner
Firms Isicoff Ragatz & Koenigsberg; Isicoff, Ragatz & Koenigsberg
Link to Docket External link to docket
Small Molecule Drugs cited in Horizon Pharma AG v. Watson Laboratories, Inc. - Florida
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Horizon Pharma AG v. Watson Laboratories, Inc. - Florida (S.D. Fla. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-08-28 1 States Patent Nos. 6,488,960 ("the '960 patent"), 6,677,326 ("the '326 patent"… COUNT I FOR INFRINGEMENT OF U.S. PATENT 6,488,960 34. Plaintiffs reallege and …have infringed one or more claims of U.S. Patent 6,488,960; B. A judgment declaring that…. This is an action for patent infringement arising under the patent laws of the United States, …,124 ("the '124 patent"), 8,168,218 ("the '218 patent"), and 8,394,407 (" External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Merck
Boehringer Ingelheim
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.